The RF Tent is intended to create an area of substantially reduced Electromagnetic Interference (EMI) in the area enclosed by the RF Tent during image acquisition by the PoleStar N-10 (K002242).

Device Description

To acquire high-quality MR images. it is necessary to isolate the MRI scanner from external sources of EMI (Electromagnetic Interference). Generally, copper sheeting is installed in the OR walls to isolate the OR from external interference. This solution is relatively expensive, and also requires the OR to be out of use during the installation process. Once the copper sheeting is installed, all procedures involving the PoleStar N-10 intraoperative MRI must be performed in the dedicated shielded room.

The RF Tent presented in this premarket notification expands the capability of the PoleStar N-10 (K002242), by providing a low cost, simple and effective alternative to the fixed copper shielding. Because it is portable, it also allows the PoleStar N-10 to be used in more than a single dedicated OR. Thereby increasing the flexibility of the use of the system.

AI/ML Overview

The provided text describes the "RF Tent" device, which is an accessory designed to reduce Electromagnetic Interference (EMI) during MRI image acquisition. The document focuses on its substantial equivalence to existing solutions (installed copper sheeting) rather than providing detailed acceptance criteria and a comprehensive study report in the format typically seen for algorithm-based devices.

Therefore, many of the requested fields cannot be directly populated from the provided text because the device is a physical RF shielding enclosure, not an AI/algorithm-based diagnostic device. The performance data section is very brief.

Here's an attempt to extract the available information and indicate where data is missing:

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria (Implied)	Reported Device Performance
Create an area of substantially reduced Electromagnetic Interference (EMI)	"Similar attenuation levels" to installed copper sheeting.
Acquire high-quality MR images by isolating the MRI scanner from external sources of EMI	"Signal to Noise results are provided in Attachment 2 of the 510(k) submission." (Specific values not provided in this document)
Proper function of the RF Tent	"We believe that the RF Tent can be safely and effectively used."

2. Sample size used for the test set and data provenance

Test Set Sample Size: Not explicitly stated. The "Performance Data" section refers to "Signal to Noise results" (plural), suggesting multiple data points or tests were conducted, but the number of tests or specific scenarios is not given.
Data Provenance: Not explicitly stated. The tests were performed by "Odin Medical Technologies." It's likely conducted in a controlled lab or clinical setting, but country of origin or whether it's retrospective/prospective is not mentioned.

3. Number of experts used to establish the ground truth for the test set and qualifications of those experts

This information is not applicable and not provided. The "ground truth" for an RF shielding device would be based on objective physical measurements of EMI attenuation and Signal-to-Noise Ratio (SNR) in MR images, not expert interpretation of diagnostic images.

4. Adjudication method for the test set

Not applicable and not provided. See point 3 above.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

Not applicable. This device is an RF shielding enclosure, not an AI or diagnostic algorithm that human readers would interact with. No MRMC study was performed or discussed.

6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

Not applicable. This is a physical device, not an algorithm.

7. The type of ground truth used

The implicit ground truth is based on physical measurements of Electromagnetic Interference (EMI) attenuation and resulting Signal-to-Noise Ratio (SNR) in Magnetic Resonance (MR) images. The text mentions "Signal to Noise results" as performance data.

8. The sample size for the training set

Not applicable. This is a physical device, not a machine learning model that requires a training set.

9. How the ground truth for the training set was established

Not applicable. This is a physical device, not a machine learning model.

Summary

{0}------------------------------------------------

K022157

Image /page/0/Picture/1 description: The image shows the logo for Odin Medical Technologies. The logo features the word "odin" in bold, sans-serif font, with the words "Medical Technologies" in a smaller font size underneath. A stylized orbit-like graphic circles the right side of the word "odin", adding a modern and technological feel to the logo. The overall design is simple, clean, and professional, conveying a sense of innovation and expertise in the medical technology field.

AUG 2 8 2002

510(k) Summary of Safety and Effectiveness

The following 510(k) Summary of Safety and Effectiveness has been prepared pursuant to requirements for 510(k) summaries specified in 21 CFR § 807.92(a).

807.92(a)(1) - Submitter Details:

Submitter name:	Adi Ickowicz - Corporate Director of Regulatory Affairs, IP and Quality
Address:	P.O. Box 548, Yokneam Elit 20692, Israel
Phone:	+972-4-959-1010
Fax:	+972-4-959-1011
E-mail:	adi@odin.co.il
Contact Person:	Adi Ickowicz - Corporate Director of Regulatory Affairs, IP and Quality
Date:	May 30, 2002

807.92(a)(2) - Device Details:

Trade Name and Common Name:	RF Tent
Classification:	21 CFR 892.1000 Magnetic ResonanceDiagnostic Device.
Class:	II
Product Code:	LNH - Magnetic Resonance ImagingSystem
Performance Standards:	No applicable performance standardshave been issued for this product codeunder section 514 of the Food and Drugand Cosmetic Act.

807.92(a)(3) - Predicate Devices:

The RF Tent is a new accessory of the PoleStar N-10 Intraoperative Magnetic Resonance Device (K002242), but it can also be considered as a modification to the presently installed copper sheeting solution to create an area of substantially reduced Electromagnetic Interference (EMI) in the area enclosed by the RF Tent.

{1}------------------------------------------------

Image /page/1/Picture/0 description: The image shows the logo for Odin Medical Technologies. The word "odin" is written in bold, sans-serif font. Below the word "odin" is the phrase "Medical Technologies" in a smaller font. A circular graphic is to the right of the word "odin", with a small dot above the "i" in "odin".

807.92(a)(4) - Device Description:

807.92(a)(5) - Device Intended Use:

ないということでするとなってきませんですけど

The RF Tent is intended to create an area of substantially reduced Electromagnetic Interference (EMI) in the area enclosed by the RF Tent during image acquisition by the PoleStar N-10 (K002242).

807.92(a)(6) - Substantial Equivalence Comparison Table:

The RF Tent and the presently implemented installed copper sheeting have the same intended use; to create an area of substantially reduced Electromagnetic Interference (EMI) in the area enclosed by these means. Both solutions use conductive means to provide similar attenuation levels.

Odin RF Tent's intended use is similar to the presently implemented installed copper sheeting, with the following main advantages:

. Initial Cost - The purchase and installation cost of the copper sheeting is approximately ten times more than the RF Cage.
. Installation - Installation of copper sheeting requires the OR to be out of use for approximately three months. There is no installation required for the RF Tent.

{2}------------------------------------------------

Image /page/2/Picture/0 description: The image shows the logo for Odin Medical Technologies. The word "odin" is written in bold, sans-serif font, with "Medical Technologies" written in a smaller font size below it. A stylized graphic of a circle with a dot on top is to the right of the word "odin."

Dedicated OR Because the RF is portable, the PoleStar N-10 does . not have to be used in a dedicated OR.

Performance Data:

Substantial equivalence was based on performance data. Signal to Noise results are provided in Attachment 2 of the 510(k) submission.

Conclusions:

The RF Tent adressed in this premarket notification, has the same intended use and technological basis as the presently implemented installed copper sheeting used with the legally marketed Intraoperative Magnetic Resonance Device PoleStar N-10 (K002242). Based on the analysis and tests performed by Odin Medical Technologies regarding the proper function of the RF Tent. We believe that the RF Tent can be safely and effectively used.

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is circular and contains the department's name around the perimeter. Inside the circle is an abstract symbol representing the human form. The symbol consists of three stylized profiles facing to the right, stacked on top of each other.

. . . . . . . . . .

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

AUG 2 8 2002

Mr. Adi Ickowicz Corporate Director of Regulatory Affairs, IP and Quality Odin Medical Technologies, Ltd. P.O. Box 548 Yokneam Elit 20692 ISRAEL

Re: K022157

Trade/Device Name: RF Tent Regulation Number: 21 CFR §892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: II Product Code: 90 LNH Dated: June 30, 2002 Received: July 2, 2002

Dear Mr. Ickowicz:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.

the first to the state of the state of the states and

{4}------------------------------------------------

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:

8xx.1xxx	(301) 594-4591
876.2xxx, 3xxx, 4xxx, 5xxx	(301) 594-4616
884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx	(301) 594-4616
892.2xxx, 3xxx, 4xxx, 5xxx	(301) 594-4654
Other	(301) 594-4692

Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.

Sincerely yours,

Nancy C. Snogdon

Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

510(k) Number (if known): K022157

RF Tent Device Name:

Indication For Use:

The RF Tent is intended to create an area of substantially reduced Electromagnetic Interference (EMI) in the area enclosed by the RF Tent during image acquisition by the PoleStar N-10 (K002242).

(PLEASE DO NOT WRITE BELOW THE LINE -- CONTINUE ON ANOTHER PAGE IF NECESSARY)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Prescription Use (Per 21 CFR 801.109) OR

Over-The-Counter Use

(Optional Format 1-2-96)

Nancy Brogdon

(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number K022157

Regulation Number and Section

§ 892.1000 Magnetic resonance diagnostic device.

(a)
Identification. A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).(b)
Classification. Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.